Pfizer (XSGO:PFE) Gross-Profit-to-Asset % : 12.11% (As of Dec. 2023)

View and export this data going back to 1951. Start your Free Trial

What is Pfizer Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Pfizer's annualized Gross Profit for the quarter that ended in Dec. 2023 was $26,744 Mil. Pfizer's average Total Assets over the quarter that ended in Dec. 2023 was $220,761 Mil. Therefore, Pfizer's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 12.11%.

Pfizer Gross-Profit-to-Asset % Historical Data

The historical data trend for Pfizer's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Gross-Profit-to-Asset % Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

20.09

20.61

30.07

34.85

15.83

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															29.84	27.28	18.27	7.29	12.11

Competitive Comparison of Pfizer's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, Pfizer's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Pfizer's Gross-Profit-to-Asset % falls into.

Pfizer Gross-Profit-to-Asset % Calculation

Pfizer's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	33542	/	( (197205	+	226501)	/ 2 )
	=	33542	/	211853
	=	15.83 %

Pfizer's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	26744	/	( (215021	+	226501)	/ 2 )
	=	26744	/	220761
	=	12.11 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Pfizer Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Pfizer's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (XSGO:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XSGO:PFE) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.